Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53 SEK | 0.00% | -4.33% | +16.10% |
May. 30 | Integrum AB Reports Earnings Results for the Fourth Quarter and Full Year Ended April 30, 2024 | CI |
May. 29 | Integrum Receives Market Approval for Opra®? Implant System in Israel | CI |
Sales 2024 * | 107M 10.3M | Sales 2025 * | 144M 13.82M | Capitalization | 977M 93.98M |
---|---|---|---|---|---|
Net income 2024 * | 4M 385K | Net income 2025 * | 8M 769K | EV / Sales 2024 * | 8.92 x |
Net cash position 2024 * | 22.76M 2.19M | Net cash position 2025 * | 23.21M 2.23M | EV / Sales 2025 * | 6.64 x |
P/E ratio 2024 * |
723
x | P/E ratio 2025 * |
117
x | Employees | 34 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 48.7% |
1 week | -4.33% | ||
Current month | +4.33% | ||
1 month | +1.53% | ||
3 months | +8.94% | ||
6 months | +34.35% | ||
Current year | +16.10% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 64 | 97-12-31 | |
Jörgen Svanström
DFI | Director of Finance/CFO | - | 23-05-01 |
Mats Dotevall
COO | Chief Operating Officer | 62 | 23-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 18-12-31 | |
Bengt Sjöholm
CHM | Chairman | 71 | 18-12-31 |
Founder | 64 | 97-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 53 | 0.00% | 15 148 |
24-06-04 | 53 | -2.21% | 32,441 |
24-06-03 | 54.2 | +6.69% | 60,657 |
24-05-31 | 50.8 | -1.55% | 67,551 |
24-05-30 | 51.6 | -6.86% | 191,912 |
Delayed Quote Nasdaq Stockholm, June 05, 2024 at 11:19 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.10% | 93.51M | |
-14.56% | 20.72B | |
+5.32% | 19.15B | |
+9.80% | 13.94B | |
-53.67% | 2.12B | |
+1.64% | 1.74B | |
+11.94% | 1.4B | |
+9.07% | 547M | |
0.00% | 400M | |
+63.82% | 179M |
- Stock Market
- Equities
- INTEG B Stock